Similar articles

• Modification of H-2 antigenic sites by enzymatic treatment influences virus-specific target cell lysis.

  Ertl HC, Koszinowski UH. Ertl HC, et al. J Immunol. 1976 Dec;117(6):2112-8. J Immunol. 1976. PMID: 993596
• Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. I. Search for target antigens in subcellular fractions.

  Todd RF, Stulting RD, Amos DB. Todd RF, et al. Cell Immunol. 1975 Aug;18(2):304-23. doi: 10.1016/0008-8749(75)90059-3. Cell Immunol. 1975. PMID: 806359 No abstract available.
• In vitro induction of cell-mediated immunity to murine leukemia cells. IV. Amplification of the generation of cytotoxic lymphocytes by enzymatically and chemically modified stimulator leukemic cells.

  Kedar E, Lupu T. Kedar E, et al. J Immunol Methods. 1978;21(1-2):35-50. doi: 10.1016/0022-1759(78)90221-1. J Immunol Methods. 1978. PMID: 659903 No abstract available.
• Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity.

  Berke G, Amos DB. Berke G, et al. Transplant Rev. 1973;17(0):71-107. doi: 10.1111/j.1600-065x.1973.tb00124.x. Transplant Rev. 1973. PMID: 4152005 Review. No abstract available.
• Immune responses to virus induced experimental leukemia and to human leukemia.

  Herberman RB. Herberman RB. Johns Hopkins Med J Suppl. 1974;3:3-14. Johns Hopkins Med J Suppl. 1974. PMID: 4371287 Review. No abstract available.